Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × OTHER × prednylidene × Clear all

Phase

Status

Active not recruiting 16 Recruiting 15 Completed 9 Terminated 7 Unknown 2 Withdrawn 1 Suspended 1

Sponsor Class

OTHER 1 NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Prostatic Neoplasms 1

Interventions

Radiotherapy 76 pembrolizumab 69 Cyclophosphamide 61 Cisplatin 55 Magnetic Resonance Spectroscopy 50 Gemcitabine 47 Radiosurgery 45 Nivolumab 42 Carboplatin 41 Paclitaxel 40 Fluorouracil 36 Dexamethasone 34 Biopsy 34 Bevacizumab 31 Oxaliplatin 30 Docetaxel 30 fludarabine 29 Radiation 29 Surveys and Questionnaires 28 Leucovorin 28 Capecitabine 28 durvalumab 27 Melphalan 25 Rituximab 24 Irinotecan 24 fludarabine phosphate 23 Cytarabine 23 Lenalidomide 22 Doxorubicin 22 Etoposide 21

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT00598858 2016-12-08

2007-5904

University of California, Irvine

Phase 2 Withdrawn

Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡